Cargando…
Von Hippel-Lindau Disease
A germline mutation in the Von-Hippel Lindau (VHL) gene predisposes carriers to development of abundantly vascularised tumours in the retina, cerebellum, spine, kidney, adrenal gland and pancreas. Most VHL patients die from the consequences of cerebellar haemangioblastoma or renal cell carcinoma. Th...
Autores principales: | Hes, Frederik J, Höppener, Jo WM, Luijt, Rob B van der, Lips, Cornelis JM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837060/ https://www.ncbi.nlm.nih.gov/pubmed/20223044 http://dx.doi.org/10.1186/1897-4287-3-4-171 |
Ejemplares similares
-
A patient with bilateral pheochromocytoma as part of a Von Hippel-Lindau (VHL) syndrome type 2C
por: Schreinemakers, Jennifer MJ, et al.
Publicado: (2007) -
Von Hippel-Lindau Disease and the Eye
por: Karimi, Saeed, et al.
Publicado: (2020) -
The incidence of consecutive manifestations in Von Hippel-Lindau disease
por: van der Horst-Schrivers, Anouk N. A., et al.
Publicado: (2019) -
Cardiac Involvement in Von Hippel-Lindau Disease
por: Valero, Ernesto, et al.
Publicado: (2016) -
Ocular Manifestations of von Hippel-Lindau Disease
por: Ruppert, Misty D, et al.
Publicado: (2019)